AXQ Capital’s RxSight RXST Stock Holding History

AXQ Capital’s Portfolio RXST Stock Details RXST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-11,851	Closed	-$73K	–	1298
2026 Q1	$73K	Sell	11,851 -7,893	-40%	-$65.5K	0.01%	903
2025 Q4	$206K	Sell	19,744 -7,370	-27%	-$74K	0.05%	559
2025 Q3	$244K	Sell	27,114 -4,011	-13%	-$35.2K	0.09%	382
2025 Q2	$405K	Buy	+31,125	New	+$468K	0.13%	274

Other funds holding RXST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

NSGL

No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

AXQ Capital's RXST Position: Q2 2026 in Review

AXQ Capital sold out of RxSight (RXST) in Q2 2026, closing a stake of 11,851 shares — an estimated $73K sold.

AXQ Capital first reported a position in RXST in Q2 2025 and held it in 4 quarters. The position peaked at $405K in Q2 2025. 152 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

AXQ Capital reported no remaining RxSight position as of Q2 2026 after selling out during the quarter.
AXQ Capital sold 11,851 RxSight shares in Q2 2026, an estimated $73K.
AXQ Capital first reported a position in RxSight in Q2 2025 and held it in 4 quarters.
AXQ Capital's RxSight position peaked at $405K in Q2 2025.
152 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.